Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sweeting

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Plos One|June 15, 2021
Modelling the impact of changes to abdominal aortic aneurysm screening and treatment services in England during the COVID-19 pandemicLois G Kim, Michael J Sweeting, Morag Armer, et al.
Journal of Vascular Surgery|May 25, 2010
Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysmsMichael J Sweeting, Simon G Thompson, Louise C Brown, et al.
JAMA|February 28, 2013
Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis, Matthew J Bown, Michael J Sweeting, et al.
The British Journal of Surgery|May 28, 2014
Cost-effectiveness of the National Health Service Abdominal Aortic Aneurysm Screening Programme in EnglandM J Glover, L G Kim, M J Sweeting, et al.
Lancet (London, England)|April 30, 2017
Morphological suitability for endovascular repair, non-intervention rates, and operative mortality in women and men assessed for intact abdominal aortic aneurysm repair: systematic reviews with meta-analysisPinar Ulug, Michael J Sweeting, Regula S von Allmen, et al.
JAMA|May 18, 2006
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsTim Bongartz, Alex J Sutton, Michael J Sweeting, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 28, 2023
Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates MattersAngus C Jennings, Mark J Rutherford, Nicholas R Latimer, et al.
Statistics in Medicine|February 20, 2016
Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administrationGraham M Wheeler, Michael J Sweeting, Adrian P Mander, et al.
Circulation|January 15, 2019
Safety of Men With Small and Medium Abdominal Aortic Aneurysms Under Surveillance in the NAAASPClare Oliver-Williams, Michael J Sweeting, Jo Jacomelli, et al.
Annals of Surgery|October 9, 2019
Optimizing Surveillance and Re-intervention Strategy Following Elective Endovascular Repair of Abdominal Aortic AneurysmsLois G Kim, Michael J Sweeting, David Epstein, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Plos One|June 15, 2021
Modelling the impact of changes to abdominal aortic aneurysm screening and treatment services in England during the COVID-19 pandemicLois G Kim, Michael J Sweeting, Morag Armer, et al.
Journal of Vascular Surgery|May 25, 2010
Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysmsMichael J Sweeting, Simon G Thompson, Louise C Brown, et al.
JAMA|February 28, 2013
Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis, Matthew J Bown, Michael J Sweeting, et al.
The British Journal of Surgery|May 28, 2014
Cost-effectiveness of the National Health Service Abdominal Aortic Aneurysm Screening Programme in EnglandM J Glover, L G Kim, M J Sweeting, et al.
Lancet (London, England)|April 30, 2017
Morphological suitability for endovascular repair, non-intervention rates, and operative mortality in women and men assessed for intact abdominal aortic aneurysm repair: systematic reviews with meta-analysisPinar Ulug, Michael J Sweeting, Regula S von Allmen, et al.
JAMA|May 18, 2006
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsTim Bongartz, Alex J Sutton, Michael J Sweeting, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 28, 2023
Perils of Randomized Controlled Trial Survival Extrapolation Assuming Treatment Effect Waning: Why the Distinction Between Marginal and Conditional Estimates MattersAngus C Jennings, Mark J Rutherford, Nicholas R Latimer, et al.
Statistics in Medicine|February 20, 2016
Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administrationGraham M Wheeler, Michael J Sweeting, Adrian P Mander, et al.
Circulation|January 15, 2019
Safety of Men With Small and Medium Abdominal Aortic Aneurysms Under Surveillance in the NAAASPClare Oliver-Williams, Michael J Sweeting, Jo Jacomelli, et al.
Annals of Surgery|October 9, 2019
Optimizing Surveillance and Re-intervention Strategy Following Elective Endovascular Repair of Abdominal Aortic AneurysmsLois G Kim, Michael J Sweeting, David Epstein, et al.
Pageof 15